Literature DB >> 9155023

Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.

K Luo1, H F Lodish.   

Abstract

The type II transforming growth factor-beta (TGF-beta) receptor Ser/Thr kinase (TbetaRII) is responsible for the initiation of multiple TGF-beta signaling pathways, and loss of its function is associated with many types of human cancer. Here we show that TbetaRII kinase is regulated intricately by autophosphorylation on at least three serine residues. Ser213, in the membrane-proximal segment outside the kinase domain, undergoes intra-molecular autophosphorylation which is essential for the activation of TbetaRII kinase activity, activation of TbetaRI and TGF-beta-induced growth inhibition. In contrast, phosphorylation of Ser409 and Ser416, located in a segment corresponding to the substrate recognition T-loop region in a three-dimensional structural model of protein kinases, is enhanced by receptor dimerization and can occur via an intermolecular mechanism. Phosphorylation of Ser409 is essential for TbetaRII kinase signaling, while phosphorylation of Ser416 inhibits receptor function. Mutation of Ser416 to alanine results in a hyperactive receptor that is better able than wild-type to induce TbetaRI activation and subsequent cell cycle arrest. Since on a single receptor either Ser409 or Ser416, but not both simultaneously, can become autophosphorylated, our results show that TbetaRII phosphorylation is regulated intricately and affects TGF-beta receptor signal transduction both positively and negatively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155023      PMCID: PMC1169800          DOI: 10.1093/emboj/16.8.1970

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors.

Authors:  L Attisano; J L Wrana; S Cheifetz; J Massagué
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

3.  Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

Authors:  L S Mathews; W W Vale
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon.

Authors:  M P Kamps
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

Authors:  K Luo; H F Lodish
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

7.  TGF beta signals through a heteromeric protein kinase receptor complex.

Authors:  J L Wrana; L Attisano; J Cárcamo; A Zentella; J Doody; M Laiho; X F Wang; J Massagué
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

8.  Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.

Authors:  M Inagaki; A Moustakas; H Y Lin; H F Lodish; B I Carr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Cloning of a second type of activin receptor and functional characterization in Xenopus embryos.

Authors:  L S Mathews; W W Vale; C R Kintner
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

10.  Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

Authors:  A Kashishian; A Kazlauskas; J A Cooper
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  38 in total

1.  A thermodynamic model for receptor clustering.

Authors:  C Guo; H Levine
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

Review 4.  Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling.

Authors:  Shaheen Ahmed; Ali Nawshad
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

5.  The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7.

Authors:  S Akoulitchev; D Reinberg
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

6.  Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

Authors:  Ichiaki Ito; Aki Hanyu; Mitsutoshi Wayama; Natsuka Goto; Yoko Katsuno; Shohei Kawasaki; Yuka Nakajima; Masashi Kajiro; Yoko Komatsu; Akiko Fujimura; Ryuichi Hirota; Akiko Murayama; Keiji Kimura; Takeshi Imamura; Junn Yanagisawa
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

7.  Modulation of type II TGF-β receptor degradation by integrin-linked kinase.

Authors:  Linda Vi; Stellar Boo; Samar Sayedyahossein; Randeep K Singh; Sarah McLean; Gianni M Di Guglielmo; Lina Dagnino
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

8.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 9.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

10.  Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.

Authors:  Maya Mouler Rechtman; Alex Nakaryakov; Keren E Shapira; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.